A WoE [weight-of-evidence] approach including an assessment of the level of uncertainty may be used to decide whether the NGI can be considered safe at the specified level,” the paper concludes. The ...

The European Medicines Agency (EMA) plans to release a reflection paper regarding when external controls can be used to generate evidence to support regulatory decisions on drug approvals. @The agency ...